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Abstract
Background: Despite significant improvements in the treatment of coronary heart disease (CHD), it is still a major
cause of mortality and morbidity among the Iranian population. Epidemiological studies have documented that risk
factors including smoking and the biochemical profile are responsible for the development of acute myocardial
infarction (AMI). Psychological factors have been discussed as potential risk factors for coronary heart disease.
Among emotional factors, depression correlates with coronary heart disease, particularly myocardial infarction.
Methods: This case-control study was conducted on 120 cases (69 males and 51 females) of acute myocardial
infarction (AMI) and 120 controls, with a mean age of 62.48 ± 15.39 years. Cases and controls were matched by
age, residence and sex.
Results: The results revealed that severe depression was independently associated with the risk of AMI (P = 0.025,
OR = 2.6, 95% CI 1.1-5.8). The analysis of variables indicated that risk factors for developing depression were
unmarried, low levels of polyunsaturated fatty acids (PUFAs), total dietary fiber (TDF) and carbohydrates. The levels
of these dietary factors were lowest in severely depressed patients compared to those categorised as moderate or
mild cases. Furthermore, severely depressed subjects were associated with higher levels of total cholesterol, high
systolic blood pressure (SBP) and WHR. Age, income, a family history of coronary heart disease, education level, sex,
employment and smoking were not associated with severe depression.
Conclusion: The present study demonstrated that severe depression symptoms are independent risk factors for
AMI. Furthermore, severe depression was associated with an unhealthy diet and AMI risk factors.
Background
Despite significant improvements in the treatment of
coronary heart disease (CHD), it is still a major cause of
mortality and morbidity among the Iranian population
[1]. Epidemiological studies have documented that risk
factors including smoking and the biochemical profile
are responsible for the development of acute myocardial
infarction (AMI) [2-4].
Psychological factors have been discussed as potential
risk factors for coronary heart disease [5]. Among emo-
tional factors, depression correlates with coronary heart
disease, particularly myocardial infarction [6]. Major
depression has been associated with approximately 20%
of patients newly diagnosed with CHD, and with
patients who have suffered but recovered from myocar-
dial infarction (MI) [7]. Depression has been related to
various heart disease risk factors such as an unhealthy
diet [8,9], anthropometric parameters, marital dissatis-
faction [10], and hypertension [11,12]. Many MI patients
s a yt h e yc o n t i n u et os m o k ea n dp e r s i s tw i t ha n
unhealthy diet because of depression, despite these
being well-known risk factors for MI [13]. While depres-
sion appears to be a risk factor for myocardial infarc-
tion, it is not clear whether it should be considered as
an independent risk factor for this disease [14].
The aim of the present study was to investigate the
association of severe depression and AMI risk factors
such as diet. In addition, we aimed to assess, after
adjusting for other variables, whether severe depression
is an independent risk factor for acute myocardial
infarction (AMI).
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This study was approved by the Ethics Committee of
the University Putra Malaysia and informed consent was
obtained from all participants before enrolment in the
study.
Study subjects and study design
This case-control study was conducted on 120 cases (69
males and 51 females) of acute myocardial infarction
(AMI) and 120 controls, with a mean age of 62.48 ±
15.39 years. AMI was defined by clinical criteria, electro-
cardiographic criteria and biochemical markers. Cases of
AMI were recruited from individuals who suffered from
chest pain and were admitted to the emergency depart-
ment of Mostafa hospital. Control cases comprised 120
individuals who received routine health checkups at the
same hospital. Cases and controls were matched by age,
residence and sex. Exclusion criteria included notable
chronic medical illness (e.g. untreated hyperthyroidism
or hyperthyroidism, renal disease or malignant disease,
and pregnancy) as these conditions could change an
individual’s lifestyle or modify the risk factors for AMI.
Cases and controls that had a history of mental illness
and received anti-depressants or other psychiatric drugs
were excluded. Furthermore, controls who had positive
electrocardiographic results were excluded.
Determination of dietary variables
A semi-quantitative food frequency questionnaire (FFQ)
developed by Willet [15] and validated extensively in sev-
eral multi-ethnic populations was used to collect dietary
information. The FFQ was used to measure long-term
(over the previous 12 months) intake of food. The list of
foods in the FFQ was modified to reflect the traditional
diet of the Ilam province. The FFQ data were obtained
during a face-to-face interview with subjects. Nutrition
IV software version 3.5.2 was used for analysis of nutrient
intake. The database included a standard reference,
which contained several different foods and nutrients,
and values for nutrients such as carbohydrates and fats.
Determination of biomarkers
The venous blood of participants was collected by a nurse
at the Mostafa Hospital between 07.00 and 09.00 hours,
12-14 hours after an overnight fast, and centrifuged
between 30 to 40 minutes after collection; blood samples
from AMI patients were collected within 24 hours of fast-
ing. Fasting levels of serum total cholesterol (TC), trigly-
cerides (TG), low density lipoproteins (LDL), high density
lipoproteins (HDL) and fasting blood sugar (FBS) were
determined using standard laboratory methods at the
Mostafa Hospital, Ilam. Fasting blood sugar (FBS) and
lipid profiles were measured using the Pars Azmoon Kit,
which has been described in earlier studies [16,17].
Blood pressure
A standard manometer was used by a nurse or physician
to measure the blood pressure (BP) of participants. The
first BP readings were taken with individuals in the sit-
ting position and after five minutes rest. Two separate
readings for the blood pressure of each participant were
taken with a 10-minute interval between them. The
averages of these readings were recorded and used for
final data analysis.
Depression questionnaire
The present study used the Centre for Epidemiological
Studies Depression Scale (CES-D) to measure depres-
sion. The CES-D was translated into Persian by the
researcher and used to obtain the cut off point for this
study.
The CES-D scale was originally developed to measure
depression. The Centre for Epidemiological Studies
developed the questionnaire with a 20-interview format
or self-report items for the purpose of measuring cur-
rent levels of symptoms of depression. These items
included appetite loss, sleep disorders, sadness, crying,
feelings of loneliness and fear. The CES-D 4-point scale
is: 0 = rarely or none of the time (less than 1 day); 1 =
some or a little of the time (1-2 days); 2 = occasionally
or a moderate amount of time (3-4 days); 3 = most or
all of the time (5-7 days).
Four items (4, 8, 12, and 16) in this questionnaire
were reversed. The total depression score was calculated
by summing up the item scores. Generally, average
scores were between 0 and 60, and higher scores indi-
cated more depressive symptoms. For the high depres-
sive symptoms category a cut-off score of 21 was used
as a determinant of severe depression. The baseline
characteristics for depression status were established in
the controls, and depression in positive cases was
assessed after three months.
Statistical analysis
SPSS for Windows version 18 was used for statistical
analyses. Cases and controls were compared using para-
metric and non-parametric tests including chi-square
test, independent sample t-test and the Mann-Whitney
U test. For final analysis, binary unconditional logistic
regression analysis was conducted to identify severe
depression as an independent risk factor for AMI in the
case-control model.
Results
The mean age of the participants was 62.48 ± 15.39
years and Table 1 presents the baseline variable data for
the 240 participants (120 cases and 120 controls). Uni-
variate analysis of continuous variables indicated that
risk factors for developing AMI were low TDF, WHR,
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family history of coronary artery disease and smoking
increased the risk of developing AMI. Most of the sub-
jects enrolled in the study had not been educated to the
level of higher secondary school or beyond and most
were also married. There were no significant differences
in terms of education level and marital status between
the experimental and control groups.
The participants were divided according to the
absence or presence of severe depression symptoms, cal-
culated from the total depression questionnaire. The
prevalences of severe depression in the case and control
groups were 36.7% and 15.8%, respectively. The present
study demonstrated that severe depression was signifi-
cantly associated with unmarried subjects. Further ana-
lyses demonstrated no significant differences between
the groups in terms of relationships between severe
depression, a family history of coronary heart disease,
education level, sex, employment and smoking (Table 2).
The analysis of variables indicated that risk factors for
developing depression were low levels of polyunsaturated
fatty acids (PUFAs), total dietary fiber (TDF) and carbo-
hydrates. The levels of these dietary factors were lowest
in severely depressed patients compared to those cate-
gorised as moderate or mild cases. Furthermore, severely
depressed subjects were associated with higher levels of
total cholesterol, high systolic blood pressure (SBP) and
WHR. Age and income were not associated with severe
depression (Table 3).
Table 4 presents crude and adjusted data concerning
severe depression associated with AMI. The results
revealed that severe depression was independently asso-
ciated with the risk of AMI (P = 0.025, OR = 2.6, 95%
CI 1.1-5.8).
Discussion
This study has demonstrated that severe depression
symptoms are independently associated with AMI, after
adjusting for other factors. In addition, lower total diet-
ary fiber (TDF), carbohydrates, higher levels of total
cholesterol (TC), a high waist-hip ratio (WHR) and high
systolic blood pressure (SBP) were associated with indi-
viduals exhibiting severe depression symptoms.
After the war between Iran and Iraq between 1980
and 1988, psychological illness increased and it is
reported that 60,000 suffer from such conditions [18].
There is a high incidence of suicide [19], believed to
reflect the high levels of depression in this region. How-
ever, there may be reasons other than genetic factors
and the war that cause depression in this population
including poor living conditions and a lack of amenities
for the general population [20].
Several studies have demonstrated that depression is
associated with higher morbidity and mortality in
patients with AMI [13,21-23]. In addition, patients who
suffer from myocardial infarction (MI) commonly
experience major depressive disorders [24]. For example,
after adjusting for other risk factors, the risk of mortality
for acute myocardial infarction is as much as four times
higher because of major depression [25].
Mechanisms underlying the relationship between
depression and CHD have yet to be elucidated. How-
ever, abnormal levels of biomedical coronary risk factors
and neurohormonal dysregulation could explain why
depression increases the occurrence of CHD or predicts
its clinical outcome. Depressed subjects often exhibit
more AMI risk factors including hypertension [26], and
hyperlipidemia than those without depression [27].
Major depressive disorders can deregulate the auto-
nomic nervous system (ANS) and the hypothalamic-
pituitary-adrenal (HPA) axis, and this deregulation can
result in elevated catecholamines and cortisol [21,23],
The ANS down-regulation predisposes patients to myo-
cardial ischemia owing to activated platelet factors [28],
such as cytokines and growth factors. These factors
accelerate atherosclerosis through the migration and
adhesion of leukocytes, the promotion of oxidized LDL
and free radicals [29].
Furthermore, HPA hyperactivity during depression
alters the blood brain barrier by deregulation of the
Table 1 Baseline variables for cases and controls
Variables Cases
(n = 120)
Mean ± SD
Controls
(n = 120)
Mean ± SD
p
Family history of CHD,% 36.7 10.8 0.000
Current smoker, % 22.5 8.3 0.002
Former smoker, % 12.5 7.5 0.197
Married, % 78.3 91.7 0.004
Education ≥ higher
secondary school, %
22.5 30.0 0.187
Employed, % 51.7 71.7 0.001
SBP (mm/Hg) 150.05 ± 14.92 139.17 ± 19.78 0.000
Income ($) 409.25 ± 194.15 395.41 ± 199.61 0.587
DBP (mm/Hg) 98.76 ± 11.28 91.65 ± 13.04 0.000
FBS (mg/dl) 129.89 ± 75.58 100.60 ± 32.23 0.000
TC (mg/dl) 217.45 ± 30.22 184.65 ± 36.19 0.000
TG (mg/dl) 177.62 ± 97.53 143.64 ± 41.68 0.001
LDL-C (mg/dl) 151.84 ± 24.55 135.55 ± 23.63 0.000
HDL-C(mg/dl) 62.70 ± 12.77 59.74 ± 12.18 0.109
TDF (g/day) 12.89 ± 5.71 17.63 ± 6.36 0.000
Carbohydrates (g/day) 219.05 ± 56.54 259.12 ± 59.27 0.000
SFA (g/day) 17.32 ± 5.83 17.86 ± 6.36 0.488
MUFA (g/day) 16.51 ± 5.92 19.20 ± 6.20 0.001
PUFA (g/day) 13.61 ± 10.14 16.93 ± 9.91 0.011
WHR 1.04 ± 0.18 0.97 ± 0.20 0.006
BMI (kg/m
2) 28.70 ± 5.36 27.96 ± 5.24 0.280
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Hyperactivity of MRD PGP induced by depression
results in reduced transport of glucocorticoids to the
brain, leading to glucocorticoid resistance [31]. It has
been well documented that the discharge of corticoster-
oids caused by HPA hyperactivity in CVD patients leads
to hypertension and hyperlipidemia [32]. Furthermore, a
reduced heart rate and variability of this rate are more
likely to be experienced by depressed subjects [33]. Such
a reduction in the heart rate has been documented as a
risk factor for cardiovascular diseases [34] including
myocardial infarction and sudden cardiac death [35].
Inflammatory marker levels are higher than normal in
depressed patients with CVD. One hypothesis is that
depression itself promotes a mild inflammatory response,
which unhealthy practices such as inactivity and cigarette
smoking may foster, and leads to deregulation of hormonal
systems (HPA) and increased susceptibility to infection.
One very sensitive inflammatory marker, C-reactive protein
(hsCRP), was shown by Kaptoge et al. [36] to be a specific
risk factor for CVD. C-reactive protein is secreted by the
liver, mainly in response to IL-1 and IL-6, which are pro-
inflammatory cytokines [37]. Secretion of these cytokines is
promoted by immune stimuli and an imbalance in them
could be involved in the pathophysiology of depression. IL-
6, a particularly potent stimulator of the HPA axis, is
secreted as part of the response to stress. This could imply
a cascade effect among physiological mechanisms and bio-
markers, which acting individually or collectively might
enhance depression and increase the risk for cardiovascular
disease [38].
During depression there are increased levels of radical
nitrogen species (RNS) and reactive oxygen species
(ROS) such as peroxide, and the activities of pro-oxidant
enzymes such as xanthine oxidase (XO) are also
increased, nitric oxide (NO) levels are changed and
there are indications of oxidative and nitrosative stress
(O&NS) damage to fatty acids and DNA [39]. Peroxide
circulates in the blood, and a recent case-control study
by Maes et al. [40] showed that major depression
patients have significantly higher plasma peroxide levels
than normal individuals.
There is also strong evidence that depression increases
oxidative damage to tissues [41,42]. Malondialdehyde
(MDA), which can modify proteins and generate
advanced lipoxidation end (ALE) products, is a by-pro-
duct of polyunsaturated fatty acid peroxidation and is a
Table 2 Categorical variables based on depression levels
Variables Severe Depression
Absent (N = 177) Present (N = 63) p
Case group/control group, % 63.3/84.2 36.7/15.8 0.000
Married, % 89.3 73.0 0.002
Education ≥ higher secondary school, % 27.7 22.2 0.398
Sex, %
Female 44.1 38.1 0.410
Male 55.9 61.9
Employed, % 62.1 60.3 0.798
Family history of CHD, % 23.7 23.8 0.990
Current smoker, % 15.3 15.9 0.907
Former smoker,% 10.2 9.5 0.883
Table 3 Continuous variables according to depression
categories among subjects
Variables Severe Depression P
Absent (N = 177) Present (N = 63)
Age 62.18 ± 15.52 63.33 ± 15.09 0.611
Income ($) 404.40 ± 201.10 396.50 ± 184.83 0.798
MUFAs (g/day) 18.33 ± 6.08 16.53 ± 6.36 0.540
PUFAs (g/day) 16.22 ± 10.16 12.61 ± 9.67 0.014
SFAs (g/day) 17.77 ± 6.09 17.07 ± 6.13 0.432
TD F(g/day) 16.02 ± 6.60 13.11 ± 5.59 0.002
BMI (kg/m
2) 28.54 ± 5.37 27.75 ± 5.10 0.298
WHR 0.99 ± 0.19 1.05 ± 0.20 0.032
Carbohydrates (g/day) 245.83 ± 63.49 220.12 ± 49.95 0.004
FBS (mg/dl) 111.80 ± 54.63 124.93 ± 72.02 0.135
SBP (mmHg) 143.14 ± 18.07 149.68 ± 17.04 0.011
DBP(mmHg) 94.33 ± 13.37 96.88 ± 13.44 0.196
TC (mg/dl) 196.55 ± 37.23 213.69 ± 33.96 0.001
LDL (mg/dl) 142.02 ± 26.35 148.39 ± 21.98 0.633
HDL (mg/dl) 60.81 ± 13.02 62.20 ± 16.17 0.346
TG (mg/dl) 160.63 ± 80.36 160.61 ± 66.16 0.999
Table 4 AMI risk by depression before and after
adjustment (N = 240)
Severe Depression OR 95% C.I p
Absent vs present (177/63) 3.1 1.7-5.7 0.000
a
Absent vs present (177/63) 2.6 1.1-5.8 0.025
b
aBefore adjustment;
bAdjustment for other variables in unconditional binary
logistic regression model controlling for anthropometrics parameter, lipid
profile, socio-demographic status, and nutrient variables.
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are significantly elevated in major depression [43]. ALEs
are pro-inflammatory and therefore detrimental, weak-
ening antioxidant defences and impairing DNA repair.
They also have a key role in atherosclerosis and neuro-
degenerative disorders [44].
In the present study, polyunsaturated fatty acids
(PUFAs) of those with severe depression were lower
than in individuals with minor or moderate depression.
Also, studies have demonstrated that a food frequency
questionnaire (FFQ) can predict the concentration of
PUFAs in the blood [45,46]. Several epidemiological [47]
and case-control studies have demonstrated that a lower
level of PUFAs is linked with depression [41,48-50] and
CVD [51]. The mechanisms that affect PUFAs are
unclear. However, one mechanism involves the regula-
tion of the serotonergic [52] and dopaminergic systems
[53]. Low levels of PUFAs predict low levels of 5-hydro-
xyindolacetic acid, a major metabolite of serotonin and
an anti-depressant, in cerebrospinal fluid [54].
There are many functional interactions between dopa-
minergic systems and other systems including the sero-
toninergic, glutamatergic, GABAergic and cholinergic
systems, which are related to behavioural processes [55].
PUFA deficiency deregulates the blood brain barrier
[56], which is important for controlling mood disorders
[57-59]. Moreover, major depression is associated with
over-activity of the inflammatory response, affecting
cytokines and alpha-interferon [60,61]. The pro-inflam-
matory series of eicosanoids are significantly affected by
polyunsaturated fatty acids [62].
This study has demonstrated a significant association
between severe depression and important dietary intake
such as TDF and carbohydrates. A recent case-control
study demonstrated significantly lower levels of dietary
fiber in depressed patients [63]. Individuals who consume
low fiber in their diets have low levels of many essential
nutrients including carbohydrates and unsaturated fatty
acids [64], and high levels of rapidly digested starches [65].
Dietary fiber affects depression itself and depression out-
comes. It modulates serum lipids [66], blood pressure [67],
inflammation [68], and waist-hip ratio (WHR) [69]. A diet
rich in fiber also contains hundreds of phytochemicals
[70], which protect neurons against injury by stimulating
the production of several antioxidant enzymes, neuro-
trophic factors, protein chaperones and other proteins that
provide neural protection against injury and disease [71].
There was a relationship between the level of severe
depression and carbohydrate intake in the subjects. Car-
bohydrates influence mood and behavior [72,73], yet the
mechanisms underlying such effects are unclear. How-
ever, carbohydrates may activate neurobiochemical path-
ways such as brain neurotransmitters that play a role in
depression [57,58]. A diet rich in carbohydrates results
in changes in blood glucose levels [74], stimulating the
release of insulin. Insulin supplies cells with sugars and
induces the transport of tryptophan (TRP) to the brain
[75], by increasing plasma TRP levels compared to other
large neutral amino acids (LNAAs) [57,58]. Therefore,
carbohydrate intake induces an increase in the TRP/
LNAA ratio, causing LNAAs to enter skeletal muscles
[58,59].
It has been reported that the waist-hip ratio (WHR) is
correlated with psychosocial factors [76], such as depres-
sion [77]. Furthermore, the body mass index (BMI) is
weakly associated with depression, and abnormalities of
the HPA axis and higher WHR is evident in patients
suffering major depression [78].
Although several studies have documented that cigar-
ette smoking is a risk factor in depressed patients
[79,80]. We found no such correlation [49,81,82]. In this
study, married subjects experienced fewer symptoms of
depression, indicating that the presence of support
affected depression in a positive manner [81,83]. There
was no link between symptoms of depression and demo-
graphic factors such as age, sex, education or family his-
tory of CHD [84].
Limitation of the study and conclusion
This case-control study investigated hospitalized AMI
patients only and further studies are required to investi-
gate an association between depression and AMI among
non-hospitalized patients. The present study demon-
strated that severe depression symptoms are indepen-
dent risk factors for AMI. Furthermore, severe
depression was associated with an unhealthy diet and
AMI risk factors. On the basis of these findings, there
are several recommendations for future research. First,
validation of the present findings is required as this is
t h ef i r s ts t u d yc o n c e r n i n gt h ep o p u l a t i o ni nI l a mp r o -
vince. A larger sample size is required, particularly for
the investigation of socio-demographic characteristics.
Furthermore, new risk factors such as C-reactive pro-
tein, malondialdehyde (MDA) and homocysteine should
be investigated in the Ilam province, as they have been
linked with depression and the risk of AMI worldwide.
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